Search results for " OSTEOPOROSIS"

showing 10 items of 92 documents

Relationship between Low Bone Mineral Density and Fractures with Incident Cardiovascular Disease: A Systematic Review and Meta-analysis

2017

An increasing evidence base suggests that low bone mineral density (BMD) and fractures are associated with cardiovascular disease (CVD). We conducted a systematic review and meta-analysis summarizing the evidence of low BMD and fractures as risk factors for future CVD. Two independent authors searched major databases from inception to August 1, 2016, for longitudinal studies reporting data on CVD incidence (overall and specific CVD) and BMD status and fractures. The association between low BMD, fractures, and CVD across longitudinal studies was explored by calculating pooled adjusted hazard ratios (HRs) ±95% confidence intervals (CIs) with a random-effects meta-analysis. Twenty-eight studie…

Maleddc:616IncidenceCARDIOVASCULAR DISEASECoronary Artery DiseaseMETA-ANALYSISOSTEOPOROSISArticleDiabetes and MetabolismFractures BoneEndocrinologyBone DensityRisk FactorsBONE MINERAL DENSITY; CARDIOVASCULAR DISEASE; META-ANALYSIS; OSTEOPOROSIS; Endocrinology Diabetes and Metabolism; Orthopedics and Sports MedicineHumansFemaleOrthopedics and Sports MedicineBONE MINERAL DENSITY
researchProduct

Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis.

2017

Monoclonal gammopathy of undetermined significance (MGUS) is a common condition in the elderly. A number of studies have investigated the relationship between MGUS and bone health outcomes including bone mineral density (BMD), osteoporosis and fractures, but no meta-analysis exists. We conducted a systematic review and exploratory meta-analysis comparing bone health outcomes in patients with MGUS. Two independent authors searched PubMed and Scopus from inception until 19 October 2016. A meta-analysis of cross-sectional and longitudinal studies investigating fractures and BMD was conducted. Standardised mean differences (SMD) ± 95% confidence intervals (CIs) were calculated for BMD, and risk…

Malemedicine.medical_specialtyAgingEndocrinology Diabetes and MetabolismOsteoporosis030209 endocrinology & metabolismMonoclonal Gammopathy of Undetermined SignificanceBone and Bones03 medical and health sciencesFractures Bone0302 clinical medicineEndocrinologyBone DensityInternal medicinemedicineOdds RatioPrevalenceHumansOrthopedics and Sports MedicineLongitudinal StudiesFemoral neckAgedBone mineralbusiness.industryIncidence (epidemiology)IncidenceGeneral MedicineMiddle Agedmedicine.diseaseConfidence intervalAging; Fractures; Monoclonal gammopathy of undetermined significance; OsteoporosisSurgeryDiabetes and Metabolismmedicine.anatomical_structureCross-Sectional StudiesMonoclonal gammopathy of undetermined signifcance Osteoporosis Fractures Aging030220 oncology & carcinogenesisMeta-analysisRelative riskCase-Control StudiesAging; Fractures; Monoclonal gammopathy of undetermined significance; Osteoporosis; Endocrinology Diabetes and Metabolism; Orthopedics and Sports Medicine; EndocrinologyOsteoporosisFemalebusinessFracturesMonoclonal gammopathy of undetermined significanceJournal of bone and mineral metabolism
researchProduct

Hyperuricemia protects against low bone mineral density, osteoporosis and fractures: a systematic review and meta-analysis

2016

Background: Serum uric acid (SUA) accounts for about 50% of extracellular antioxidant activity, suggesting that hyperuricemia may have a protective role in diseases characterized by high levels of oxidative stress, such as osteoporosis. We aimed to meta-analyse data regarding bone mineral density (BMD), osteoporosis and fractures in people with higher SUA vs. lower SUA concentrations. Materials and methods: Two investigators conducted a literature search using PubMed and Scopus, without language restrictions. Standardized mean differences (SMDs) and 95% confidence intervals (CIs) were used for BMD; risk ratios (RRs) and adjusted odds ratios (ORs) for cross-sectional data. Most possible adju…

Malemedicine.medical_specialtyBone densityClinical BiochemistryOsteoporosis030209 endocrinology & metabolismBone mineral density; fractures; hyperuricemia; osteoporosis; uric acid; Bone Density; Epidemiologic Methods; Female; Humans; Hyperuricemia; Male; Osteoporosis; Osteoporotic Fractures; Uric AcidhyperuricemiaBiochemistryBone remodelingNO03 medical and health sciences0302 clinical medicineBone mineral density; fractures; hyperuricemia; osteoporosis; uric aciduric acidBone DensityInternal medicinemedicineBone mineral densityHumansHyperuricemiaFemoral neck030203 arthritis & rheumatologyBone mineralbusiness.industryHazard ratioGeneral MedicineOdds ratiofracturesmedicine.diseaseosteoporosismedicine.anatomical_structureEndocrinologyFemalebusinessEpidemiologic MethodsOsteoporotic FracturesBone mineral density fractures hyperuricemia osteoporosis uric acid.
researchProduct

High prevalence of fragility vertebral fractures in patients hospitalised in Internal Medicine Units. Results of the POINT (Prevalence of Osteoporosi…

2015

Abstract Background Osteoporotic vertebral fractures (VFs) often go unrecognised in both healthy individuals and in pathological conditions. Few data exist on VFs in patients hospitalised in Internal Medicine Units (IMUs), who often suffer from multiple concomitant chronic disorders. Aim of the study This multicentre cross-sectional study was aimed at assessing the prevalence of VFs in an unselected population of patients referring to IMUs. Correlations between VFs and the main coexisting diseases were also investigated. Methods Information on demographic, clinical and laboratory findings, and on the presence of known risk factors for osteoporosis was recorded. The Genant's semi-quantitativ…

Malemedicine.medical_specialtyHistologyPhysiologyEndocrinology Diabetes and MetabolismOsteoporosisPrevalenceVery frequentEndocrinologyInternal medicineInternal MedicinePrevalenceMedicineHumansIn patientvertebral fracturesPathologicalAgedDemographybusiness.industryMiddle Agedmedicine.diseaseComorbidityinternal medicine; osteoporosis; vertebral fracturesosteoporosisSpineHospitalizationDiabetes and Metabolisminternal medicineLogistic ModelsConcomitantVertebral fracturesCohortMultivariate AnalysisOsteoporosis vertebral fractures Genant's semi-quantitative methodOsteoporosisSpinal FracturesFemaleInternal medicine; Osteoporosis; Vertebral fractures; Aged; Demography; Female; Hospitalization; Humans; Internal Medicine; Logistic Models; Male; Middle Aged; Multivariate Analysis; Osteoporosis; Prevalence; Spinal Fractures; Spine; Endocrinology Diabetes and Metabolism; Histology; Physiologybusiness
researchProduct

Serum uric acid and incident osteoporotic fractures in old people: The PRO.V.A study

2015

Purpose: Although high serum uric acid (SUA) levels are associated with negative outcomes in older people, recent studies reported that hyperuricemia could help protect against the onset of bone fractures. We consequently examined whether baseline SUA levels were associated with risk of incident osteoporotic fractures in a representative group of elderly people with no fractures or other bone-modifying conditions or drugs at the baseline. Methods: Among 3099 people aged ≥ 65. years initially involved in the PRO.V.A. study, 1586 participants with no prior diagnosis of osteoporotic fractures, and no conditions or medication affecting bone metabolism at the baseline were followed up for 4.4. ±…

Malemedicine.medical_specialtyHistologyPhysiologyEndocrinology Diabetes and MetabolismOsteoporosisserum uric acid (SUA)Bone remodelingchemistry.chemical_compoundAbsorptiometry PhotonElderlySerum uric acidEndocrinologyRisk FactorsInternal medicinemedicineHumansHyperuricemiaAbsorptiometryAgedProportional Hazards Modelsbusiness.industryProportional hazards modelIncidence (epidemiology)IncidenceMedicine (all)Serum uric acidConfoundingmedicine.diseaseCommunity-dwelling adultsPhotonSurgeryUric AcidCommunity-dwelling adults; Elderly; Fractures; Osteoporosis; Serum uric acid; Absorptiometry Photon; Aged; Female; Humans; Incidence; Male; Osteoporosis; Osteoporotic Fractures; Proportional Hazards Models; Risk Factors; Uric Acid; Physiology; Endocrinology Diabetes and Metabolism; Histology; Medicine (all)Diabetes and MetabolismchemistryUric acidOsteoporosisFemalebusinessFracturesOsteoporotic Fractures
researchProduct

Pro-inflammatory dietary pattern is associated with fractures in women: an eight-year longitudinal cohort study

2017

Summary: In this study, during 8 years of follow-up, we reported that higher dietary inflammatory index values were associated with a higher risk of incident fractures in women, but not in men, after adjusting for potential confounders. Introduction: Inflammation is a key risk factor for many adverse outcomes in older people. While diet is a potential source of inflammation, little is known about the impact of inflammatory diet on fractures. Thus, we investigated whether higher Dietary Inflammatory Index (DII)™ ® scores are associated with fractures in a cohort of North American people. Methods: This longitudinal study with a follow-up of 8 years included 3648 participants (1577 males and 2…

Malemedicine.medical_specialtyLongitudinal studyEndocrinology Diabetes and MetabolismOsteoporosis*Dietary Inflammatory Index030209 endocrinology & metabolismDiet SurveysRisk AssessmentArticleDietary Inflammatory IndexCohort Studies03 medical and health sciencesSex Factors0302 clinical medicine*InflammationInternal medicinemedicineHumans030212 general & internal medicine*OsteoporosisRisk factorAgedddc:616Inflammationbusiness.industryIncidenceIncidence (epidemiology)Hazard ratioConfoundingMiddle Agedmedicine.diseaseUnited StatesDietFracture*FractureOrthopedic surgeryCohortPhysical therapyOsteoporosisFemale*AgedbusinessAged; Dietary Inflammatory Index; Fracture; Inflammation; OsteoporosisOsteoporotic FracturesFollow-Up StudiesOsteoporosis International
researchProduct

Prescription of anti-osteoporosis medications after hospitalization for hip fracture: a multicentre Italian survey.

2017

Purpose: Literature data indicate that the proportion of patients with recent hip fracture who receive a prescription for anti-osteoporotic drugs is low and does not seem to increase over time. This study aimed to obtain data on the prescription for anti-osteoporotic drugs in Italian patients discharged after a recent hip fracture and to assess which variables could have influenced the decision for prescribing osteoporosis medication. Methods: A total of four Italian centres located in four different geographical areas (Siena, Verona, Naples and Palermo) participated in this retrospective study. In each centre, experienced clinicians gathered the data of up to 200 consecutive patients disch…

Malemedicine.medical_specialtyPediatricsHip fracture; Anti-osteoporotic drugs; Comorbidities; Ca/vitamin D supplementsAgingAnti-osteoporotic drugs; Ca/vitamin D supplements; Comorbidities; Hip fractureAnti-osteoporotic drugOsteoporosisAlternative medicine030209 endocrinology & metabolismComorbiditiesHip fracture03 medical and health sciences0302 clinical medicineSex FactorsSurveys and QuestionnairesmedicineHumans030212 general & internal medicineMedical prescriptionPractice Patterns Physicians'AgedRetrospective StudiesAged 80 and overHip fractureBone Density Conservation AgentsGeriatrics gerontologybusiness.industryHip FracturesSettore MED/34 - Medicina Fisica E RiabilitativaRetrospective cohort studyMean ageMiddle Agedmedicine.diseaseCa/vitamin D supplementsHospitalizationAnti-osteoporotic drugsItalyAnti osteoporosisPhysical therapyAnti-osteoporotic drugs; Ca/vitamin D supplements; Comorbidities; Hip fracture; Aging; Geriatrics and GerontologyOsteoporosisFemaleCa/vitamin D supplementComorbiditieGeriatrics and GerontologybusinessOsteoporotic FracturesAging clinical and experimental research
researchProduct

The incidence of hip, forearm, humeral, ankle, and vertebral fragility fractures in Italy: results from a 3-year multicenter study

2010

Introduction: We aimed to assess the incidence and hospitalization rate of hip and "minor" fragility fractures in the Italian population.Methods: We carried out a 3-year survey at 10 major Italian emergency departments to evaluate the hospitalization rate of hip, forearm, humeral, ankle, and vertebral fragility fractures in people 45 years or older between 2004 and 2006, both men and women. These data were compared with those recorded in the national hospitalizations database (SDO) to assess the overall incidence of fragility fractures occurring at hip and other sites, including also those events not resulting in hospital admissions.Results: We observed 29,017 fractures across 3 years, with…

Malemedicine.medical_specialtySettore MED/06 - Oncologia MedicaOsteoporosisImmunologyWristFractures BoneForearmCost of IllnessRheumatologymedicineSettore MED/33 - Malattie Apparato LocomotoreHumansImmunology and AllergyHumerusStatistics & numerical dataBoneAgedbusiness.industryhip fractures vertebral fracturesIncidence (epidemiology)Settore MED/34 - Medicina Fisica E RiabilitativaIncidenceAged; Cost of Illness; Female; Forearm Injuries; epidemiology/etiology; Fractures; Bone; Hip Injuries; Hospitalization; statistics /&/ numerical data; Humans; Humerus; injuries; Incidence; Italy; epidemiology; Male; Middle Aged; Osteoporosis; complications; Spinal Fracturesfragility fractures; osteoporosisfragility fracturesForearm InjuriesHumerusMiddle Agedmedicine.diseaseMale; Middle Aged; Hip Injuries; Humerus; Spinal Fractures; Cost of Illness; Female; Forearm Injuries; Italy; Hospitalization; Humans; Osteoporosis; Fractures Bone; Aged; IncidenceSurgeryHospitalizationmedicine.anatomical_structureItalyOrthopedic surgeryPhysical therapyOsteoporosisSpinal FracturesFemaleAnklebusinessFracturesHip InjuriesResearch ArticleArthritis Research & Therapy
researchProduct

Polymyalgia rheumatica and vertebral fractures: a 1-year pilot controlled study

2010

No data exist about the possibility that vertebral fracture in PMR patients could be independent of steroid therapy. For this reason, we aimed to investigate this topic by a case cohort study with a 1-year follow-up for each patient. We selected ten consecutive patients who experienced vertebral fractures (VF-group) during the first month of 1-year follow-up period and without any other significant associated condition. As a control group we studied ten control patients, without vertebral fractures and with a follow-up of 1 year, randomly selected among a larger group of patients affected by polymyalgia rheumatica. The following data were analysed: eritrosedimention rate (ESR), visual analo…

Malemedicine.medical_specialtyTime FactorsSettore MED/09 - Medicina Internamedicine.drug_classGiant Cell ArteritisImmunologyOsteoporosisPilot Projectslaw.inventionCohort StudiesPolymyalgia rheumaticaRheumatologyRandomized controlled triallawInternal medicinemedicineHumansImmunology and AllergyAgedPain Measurementbusiness.industryCase-control studymedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheRheumatologySurgerySettore MED/16 - ReumatologiaGiant cell arteritisTreatment OutcomePolymyalgia RheumaticaCase-Control StudiesPolymyalgia rheumatica Vertebral fractures Osteoporosis Controlled clinical trialSpinal FracturesCorticosteroidFemalebusinessFollow-Up StudiesCohort studyRheumatology International
researchProduct

BRONJ in patients with rheumatoid arthritis: A multicenter case series

2016

Objective: Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of various medications (bisphosphonates, anti-resorptive, and anti-angiogenic drugs). ONJ pathogenesis is still unclear although some risk factors have been recognized. Of these, rheumatoid arthritis (RA) has been hypothesized as a potential risk factor for developing ONJ. This observational study will describe a multicenter case series of patients affected with RA and ONJ, and it will attempt to evaluate the association between features of ONJ and pharmacological, systemic, and site variables. Methods: Demographic, pharmacological, and clinical data from 18 RA patients with ONJ were collected and registered fr…

Malemedicine.medical_specialtymedicine.medical_treatmentOsteoporosisONJArthritis Rheumatoid03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansBisphosphonateONJ; Bisphosphonate; Denosumab; Jaw; Osteonecrosis; Osteoporosis; Rheumatoid arthritis; Dentistry (all); Otorhinolaryngology2734 Pathology and Forensic MedicineRheumatoid arthritisAdverse effectGeneral DentistryRheumatoid arthritiAgedBisphosphonate-associated osteonecrosis of the jawbusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineOsteoporosiOsteonecrosis030206 dentistryBisphosphonateMiddle Agedmedicine.diseaseSurgeryDenosumabOtorhinolaryngologyJaw030220 oncology & carcinogenesisRheumatoid arthritisOsteonecrosiDentistry (all)OsteoporosisMethotrexateBisphosphonate-Associated Osteonecrosis of the JawFemaleDenosumabbusinessOsteonecrosis of the jawmedicine.drug
researchProduct